Roche
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Roche was mentioned 36 times in 11 outlets across 3 countries over the last 12 months. 36% of that coverage was positive and 6% negative. 92% was editorial rather than PR or paid placement.
MENTIONS · 12M
36
36 all-time
OUTLETS · 12M
11
in 3 countries
AVG SENTIMENT
+0.236
EDITORIAL
92%
3 PR · 33 editorial
Recent coverage
Resilient Roche Holding stock steadies after fresh pipeline deals and solid H1 2026 results. - ad-hoc-news.de
ad-hoc-news.de · DE · 31 Aug 2026 · positive
New Orleans judge who oversaw grand jury that indicted AG Murrill recused from 50+ cases - NOLA.com
nola.com · INT · 28 Aug 2026 · negative
Genentech’s US manufacturing facility advances with construction milestone - PMLiVE
pmlive.com · INT · 28 Aug 2026 · positive
Roche's tests can identify HER2 status in esophageal cancer for the first time - Stock Titan
stocktitan.net · INT · 26 Aug 2026 · positive
Roche Invests $750m to Double US Manufacturing Plant - Construction Digital
constructiondigital.com · INT · 24 Aug 2026 · positive
Is Roche Holding (SWX:ROP) Fully Valued After Its Latest US Manufacturing Push? - Yahoo Finance
finance.yahoo.com · INT · 21 Aug 2026 · positive
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States - Yahoo Finance
finance.yahoo.com · US · 20 Aug 2026 · positive
Shane Richie - Wikipedia
en.wikipedia.org · INT · 16 Aug 2026 · positive
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 0 |
| 2026-01 | 0 |
| 2026-02 | 0 |
| 2026-03 | 0 |
| 2026-04 | 0 |
| 2026-05 | 5 |
| 2026-06 | 15 |
| 2026-07 | 7 |
| 2026-08 | 9 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Roche against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page